Department of Anesthesiology, Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China.
State Key Laboratory of Pharmaceutical Biotechnology, The University of Hong Kong, Hong Kong, China.
J Cell Mol Med. 2017 Oct;21(10):2503-2513. doi: 10.1111/jcmm.13171. Epub 2017 Apr 12.
Hepatic ischaemia/reperfusion (HIR) induces severe damage on hepatocyte cell membrane, which leads to hepatocyte death and the subsequent HIR injury. In this study, we investigated the role and the mechanism of mitsugumin-53 (MG53), a novel cell membrane repair protein, in protecting the liver against HIR injury. Rats were subjected to sham operation or 70% warm HIR with or without recombined MG53 (rhMG53), caudal vein-injected 2 hrs before inducing HIR. In vitro, cultured hepatocyte AML12 cells were subjected to hypoxia/reoxygenation (H/R) in the presence of rhMG53 and/or dysferlin gene shRNAs or adenovirus transfection. HIR resulted in severe liver injury manifested as severe liver histological changes and increased AST and ALT release. Post-ischaemic hepatic oxidative stress was significantly enhanced demonstrated by elevated dihydroethidium level, increased 4-hydroxynonenal, enhanced 15-F2t-isoprostane and decreased SOD activity. rhMG53 administration attenuated post-HIR liver injury, decreased liver oxidative stress and further enhanced dysferlin protein expression and its colocalization with MG53. Similarly, H/R induced AML12 cell injury and oxidative stress, which were abolished by either rhMG53 or dysferlin overexpression but were exacerbated by dysferlin gene knockdown. Dysferlin overexpression further increased H/R-induced increased colocalization of MG53 and dysferlin. In conclusion, MG53 was anchored by dysferlin to reduce oxidative stress and cell death and attenuate HIR injury.
肝缺血/再灌注(HIR)导致肝细胞细胞膜严重损伤,进而导致肝细胞死亡和随后的 HIR 损伤。在这项研究中,我们研究了一种新型细胞膜修复蛋白——mitsugumin-53(MG53)在保护肝脏免受 HIR 损伤中的作用和机制。大鼠接受假手术或 70%温热 HIR,并用或不用重组 MG53(rhMG53)预处理,即在诱导 HIR 前 2 小时经尾静脉注射。在体外,培养的肝细胞 AML12 细胞在 rhMG53 和/或 dysferlin 基因 shRNA 或腺病毒转染存在的情况下经历缺氧/复氧(H/R)。HIR 导致严重的肝损伤,表现为严重的肝组织学变化和增加的 AST 和 ALT 释放。缺血后肝氧化应激明显增强,表现在二羟乙啶水平升高、4-羟基壬烯醛增加、15-F2t-异前列腺素增加和 SOD 活性降低。rhMG53 给药减轻了 HIR 后的肝损伤,降低了肝氧化应激,进一步增强了 dysferlin 蛋白表达及其与 MG53 的共定位。同样,H/R 诱导 AML12 细胞损伤和氧化应激,这两种作用均被 rhMG53 或 dysferlin 过表达所消除,但被 dysferlin 基因敲低所加剧。dysferlin 过表达进一步增加了 H/R 诱导的 MG53 和 dysferlin 共定位的增加。总之,MG53 被 dysferlin 锚定以减少氧化应激和细胞死亡,并减轻 HIR 损伤。